Anzeige
Mehr »
Login
Montag, 24.02.2025 Börsentäglich über 12.000 News von 688 internationalen Medien
851 % Rendite in 30 Tagen: Die KI-Aktie, die seit der Integration von Deepseek R1 Wellen schlägt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40H7V | ISIN: SE0022574331 | Ticker-Symbol: 4HG0
Frankfurt
21.02.25
08:05 Uhr
0,168 Euro
-0,007
-4,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
QLIFE HOLDING AB Chart 1 Jahr
5-Tage-Chart
QLIFE HOLDING AB 5-Tage-Chart

Aktuelle News zur QLIFE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
QLIFE Aktie jetzt für 0€ handeln
FrQLIFE HOLDING AB: The subscription period in Qlife's rights issue ends on Tuesday, 25 February 20251
FrQLIFE HOLDING AB: Qlife has successfully verified the biomarkers related to the previously announced LOI1
17.02.QLife Holding AB: Qlife announces the launch of Egoo.AI and the start of sales for the Women's Health platform58 Qlife is proud to announce a major expansion of Egoo.Health with the launch of Egoo.AI, an advanced AI-driven platform designed to provide users with personalized insights based on biomarker test results...
► Artikel lesen
14.02.QLIFE HOLDING AB: Qlife launches Thyroid Disease and Vitamin D biomarkers, now available for immediate sales1
10.02.QLIFE HOLDING AB: Qlife publishes information memorandum due to upcoming rights issue1
09.02.Qlife zeigt deutliche Umsatzsteigerung trotz Jahresverlust2
06.02.QLife Holding AB: QLIFE HOLDING AB, Interim Report Q4, October to December 202489Transition to a commercial business Financial summary - fourth quarter 2024 Revenue in the period amounted to kSEK 50 (30). EBITDA for the period amounted to kSEK -7,721 (-86,903), and net loss...
► Artikel lesen
05.02.XFRA CAPITAL ADJUSTMENT INFORMATION - 05.02.202593Das Instrument MI6 AU000000MWY2 MIDWAY LTD EQUITY wird cum Kapitalmassnahme gehandelt am 05.02.2025 und ex Kapitalmassnahme am 06.02.2025 The instrument MI6 AU000000MWY2 MIDWAY LTD EQUITY is traded...
► Artikel lesen
31.01.QLife Holding AB: Qlife comments on the CEO of the company getting a sanction from Finansinspektionen96The CEO of Qlife Thomas Warthoe has been sanctioned by Finansinspektionen related to insider information. The sanction relates to an incident in February 2023 when Thomas Warthoe forwarded an email...
► Artikel lesen
29.01.QLife Holding AB: Qlife carries out a rights issue of approximately SEK 11.8 million and enters into an agreement for a credit facility of SEK 5.6 million50NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA...
► Artikel lesen
28.01.QLIFE HOLDING AB: Qlife has signed a letter of intent with a top-20 global Pharma company to explore a potential commercial collaboration2
16.01.QLIFE HOLDING AB: Qlife announces introduction of a CE-approved joint developed Egoo Health platform for immediate sales1
14.01.QLife Holding AB: Qlife provides sales and regulatory updates92The company has shifted its focus from research and development to becoming a sales-driven organization, emphasizing the distribution of its high-quality Egoo Health product platform in the rapidly...
► Artikel lesen
07.01.QLife Holding AB: Qlife provides update on operational progress in China83Since the summer, Qlife has been working diligently in close collaboration with its partner, Hipro Biotechnology, in China. The company is pleased to share the following updates: Excellent clinical...
► Artikel lesen
21.11.24QLIFE HOLDING AB: The exercise period for warrants of series TO 5 in Qlife Holding begins today, 21 November 20243
11.11.24QLIFE HOLDING AB: Qlife announces outcome in directed issues1
08.11.24Bulletin from the extraordinary general meeting, and the second control meeting, in Qlife Holding AB on 8 November 20241
07.11.24QLife Holding AB: QLIFE HOLDING AB, Interim Report Q3, July to September 202479Finally there Financial summary - third quarter 2024 Revenue in the period amounted to kSEK 0 (45). EBITDA for the period amounted to kSEK -27,151 (-6,660), and net loss kSEK - 28,087 (-8,926). The...
► Artikel lesen
07.10.24QLIFE HOLDING AB: Qlife withdraws proposal to change company name1
01.10.24QLIFE HOLDING AB: Qlife starts sales of its PHE rare disease test, addressing an unmet need in the at-home testing market worth SEK 2.5 billion2
Seite:  Weiter >>
34 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1